The European Medicines Agency has outlined a set of actions to be taken over the next three years to strengthen its relations with academia, as part of an initiative that the agency says will help it keep up with relevant scientific developments while giving academic start-ups regulatory advice on how to turn their research into new medicines.
The new framework for interactions between the EMA and the academic community aims to raise awareness among academia...







